Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2023-10-15
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the time of testing, participants will first complete a series of questionnaires. These questionnaires will provide information about the daily functioning of all participants. The participants' shoulder strength will also be measured.
After applying the IMUs, the participant will first perform a maximal movement (active for participant) in 4 directions (forward and lateral lifting of arm, hand-to-neck , hand-to-back). Then the researcher will perform the same movements with the participant's arm (passive for participant). This will allow measurement of the maximum active and passive mobility of the shoulder. Next, the participant will be asked to place and take back a number of different objects (both in terms of size and weight) at predetermined heights.
The participants without shoulder pain will be tested once, the participants with a reverse shoulder arthroplasty we want to test 4 times. The participants without shoulder pain will be assigned to the control group. The participants with a reverse shoulder arthroplasty we want to test 4 times to monitor not only their movement pattern, but also any changes in this pattern .
The questionnaires, strength measurement and requested movements will be the same for both groups.
Analysis of these movements will provide us with insights that can help improve the functional rehabilitation of patients with a reverse shoulder prosthesis.
All participants with a reverse shoulder arthroplasty will be recruited at UZ, participants without shoulder pain will be recruited through different channels (these are not patients)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy participants
no shoulder pain no shoulder diagnosis 60 years and older
IMU (Inertial Measurement Devices)
Functional placing and reaching of objects of different weights on different heights
RSA participants
primary reverse shoulder arthroplasty 60 years and older
IMU (Inertial Measurement Devices)
Functional placing and reaching of objects of different weights on different heights
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IMU (Inertial Measurement Devices)
Functional placing and reaching of objects of different weights on different heights
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no shoulder pain + no diagnosis of shoulder problem
* primary reverse shoulder arthroplasty
Exclusion Criteria
* shoulder pain at moment of testing
* known shoulder problem ( incl. diagnosis)
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Van Tongel, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Ghent, University Ghent
Ann Cools, PhD
Role: STUDY_CHAIR
University Ghent
Annelies Maenhout, PhD
Role: STUDY_CHAIR
University Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghent University Hospital
Ghent, , Belgium
University Ghent
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dominiek Vandenbosch, Msc
Role: primary
Alexander Van Tongel, PhD
Role: backup
Dominiek Vandenbosch, MSc
Role: primary
Annelies Maenhout, Phd
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONZ-2023-0416
Identifier Type: -
Identifier Source: org_study_id